Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

The words "recession proof" written on a pink sticky note. bulletproof stocks

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024

These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks

7 Dependable Dividend Stocks for Long-Term Income

Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.

medicine research, pharmaceutical background, LJPC stock

3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct

These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.

Other industries you might be interested in

Icon depicting a DNA strand

Biotech

Marijuana leaf

Cannabis

Icon depicting pills

Psychedelics

Recent Healthcare Stocks Articles

Why Is Reshape Lifesciences (RSLS) Stock Up 136% Today?

By William White, InvestorPlace Writer
Reshape Lifesciences (RSLS) stock is rocketing higher on Friday as a filing mixup shines a light on the company's shares.

7 F-Rated Stocks to Sell in February

By Louis Navellier and the InvestorPlace Research Staff
Now that we’re getting an idea of what the market holds for us this year, we can make a fair estimate of F-rated stocks to sell this month.

The 7 Most Undervalued Biotech Stocks to Buy in February 2023

By Josh Enomoto, InvestorPlace Contributor
Get your hands on the latest medical innovations at a compelling discount with the most undervalued biotech stocks to buy.

3 Defensive Stocks to Buy If You Think the Market Is Headed Lower

By Chris MacDonald, InvestorPlace Contributor
For those concerned about the potential for the market to decline further, these defensive stocks certainly have your back right now.

The 3 Most Undervalued Penny Stocks to Buy in February 2023

By Chris Markoch, InvestorPlace Contributor
Here are three penny stocks in emerging sectors that look to be undervalued relative to the consensus price target of analysts.

Why Is Biophytis (BPTS) Stock Up 69% Today?

By William White, InvestorPlace Writer
Biophytis (BPTS) stock is taking off on Thursday after the company released positive results from a Phase 2/3 clinical trial.

Cathie Wood Is Doubling Down on This Hidden-Gem Artificial Intelligence Stock

By Samuel O'Brient, InvestorPlace Reporter
Cathie Wood thinks Exact Sciences can ride the AI boom to the top. Here's what investors need to know about EXAS stock.

Why Is OncoSec Medical (ONCS) Stock Down 25% Today?

By William White, InvestorPlace Writer
OncoSec Medical (ONCS) stock is falling on Thursday after the company revealed some details of a planned stock offering.

Why Is ZyVersa Therapeutics (ZVSA) Stock Up 94% Today?

By William White, InvestorPlace Writer
ZyVersa Therapeutics (ZVSA) stock is flying higher on Thursday as investors react to a preliminary prospectus for a stock offering.

Why Is Tenax Therapeutics (TENX) Stock Up 149% Today?

By William White, InvestorPlace Writer
Tenax Therapeutics (TENX) stock is rocketing higher on Thursday after getting an update on one of its U.S. medical patents.

Why Did Bright Green (NASDAQ:BGXX) Stock Gain 170% Today?

By Chris MacDonald, InvestorPlace Contributor
Today, shareholders in New Mexico-based cannabis company Bright Green and BGXX stock are seeing impressive gains on key news.

3 Sorry Pharma Stocks to Sell in February Before It’s Too Late

By Faisal Humayun, InvestorPlace Contributor
These are the pharma stocks to sell, as they represent companies with weak fundamentals and sustained cash burn visibility.

Why Is Invacare (IVC) Stock Down 20% Today?

By William White, InvestorPlace Writer
Invacare (IVC) stock is falling on Wednesday after the company announced a new set of bonuses for its executives and a bankruptcy.

Why Is TransCode Therapeutics (RNAZ) Stock Up 45% Today?

By William White, InvestorPlace Writer
TransCode Therapeutics (RNAZ) stock is rocketing higher on Wednesday following positive study results treating melanoma.

The 3 Most Undervalued Stocks in India for Your February Buy List

By Faisal Humayun, InvestorPlace Contributor
These are a few of the top undervalued stocks in India, providing investors with exposure to strong growth outlooks in the coming years.

Why Is Hillstream BioPharma (HILS) Stock Up 100% Today?

By David Moadel, InvestorPlace Contributor
HILS stock is making a 2x move to the upside today as traders learn about Hillstream BioPharma's tech-focused team-up to target cancer.

7 Healthcare Stocks That Will Be Big Winners in 2023

By Alex Sirois, InvestorPlace Contributor
Healthcare stocks had a strong 2022 which will continue throughout 2023 making these picks ones to consider.

Why Is ContraFect (CFRX) Stock Up 20% Today?

By William White, InvestorPlace Writer
ContraFect (CFRX) stock is rising higher on Tuesday as investors await news about its potential delisting from the Nasdaq Capital Market.

7 CRISPR Stocks With the Best Long-Term Potential 

By Alex Sirois, InvestorPlace Contributor
CRISPR stocks are becoming commercially viable leading to substantial returns in 2023 and beyond, as the technology will only improve.
Load More Articles